Legend Capital

Legend Capital Legend Capital is a subsidiary of Legend Holdings, managing $10B+ across roughly 600 companies since 2001. The firm is raising Fund VIII and Healthcare Fund II, targeting $1B+ each. The portfolio includes 12 unicorns, 54 IPOs, and 21 acquisitions including Didi, Baidu, and Pharmaron. Focus areas span TMT, healthcare, consumption, enterprise services, and intelligent manufacturing. The firm prefers Series A and B in China-based startups, with 257 tech companies, 143 consumer, and 8